Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process. ICER isn't officially involved in the price negotiations introduced ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

The decision could significantly expand use of what is already one of the industry’s best-selling ... pulmonary disease, or COPD, that can’t be controlled with other medications.

Regeneron and Sanofi shares edged higher Friday after their drug to treat chronic obstructive pulmonary disease (COPD) received approval from the Food and Drug Administration (FDA). The drug ...